Are you Dr. Scott?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8311
Summary
- Dr. Emma Scott, MD is a hematologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon and Pennsylvania. She is affiliated with OHSU Hospital and is an Assistant Professor at Oregon Health and Science University School of Medicine.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2008 - 2011
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2004 - 2008
- University of the WitwatersrandClass of 2000
Certifications & Licensure
- OR State Medical License 2011 - 2025
- PA State Medical License 2004 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
- Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 138 citationsImproved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, Mei-Jie Zhang, Jiaxing Huang
Journal of Clinical Oncology. 2015-09-14 - 256 citationsB-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.Nina Shah, Ajai Chari, Emma C. Scott, Khalid Mezzi, Saad Z. Usmani
Leukemia. 2020-02-13 - 286 citationsCombined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.Dan T. Vogl, Edward A. Stadtmauer, Kay See Tan, Daniel F. Heitjan, Lisa E. Davis
Autophagy. 2014-05-20